Immunisation Community of Practice

Share Immunisation Community of Practice on Facebook Share Immunisation Community of Practice on Twitter Share Immunisation Community of Practice on Linkedin Email Immunisation Community of Practice link

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.
  • Update to the Australian Immunisation Handbook

    Share Update to the Australian Immunisation Handbook on Facebook Share Update to the Australian Immunisation Handbook on Twitter Share Update to the Australian Immunisation Handbook on Linkedin Email Update to the Australian Immunisation Handbook link

    The Australian Immunisation Handbook has recently updated a number of pages and the updates can be viewed on the Handbook website.

  • AIR 42A Report update Dec 2022

    Share AIR 42A Report update Dec 2022 on Facebook Share AIR 42A Report update Dec 2022 on Twitter Share AIR 42A Report update Dec 2022 on Linkedin Email AIR 42A Report update Dec 2022 link

    From 3 December 2022 the AIR042A report will be temporarily unavailable whilst enhancements are made to improve usability and to future proof the report so that it is aligned with evolving clinical advice regarding multiple boosters and new COVID-19 vaccines. Vaccination providers will still be able to access and view reports that they’ve requested prior to 3 December 2022.

    It is anticipated the enhanced AIR042A report will be available for vaccination providers to use from March 2023.

    You need to be signed in to add your comment.

  • Expansion of the NSW pharmacist vaccination program

    Share Expansion of the NSW pharmacist vaccination program on Facebook Share Expansion of the NSW pharmacist vaccination program on Twitter Share Expansion of the NSW pharmacist vaccination program on Linkedin Email Expansion of the NSW pharmacist vaccination program link

    The NSW pharmacist vaccination program has been expanded to include 6 additional vaccines:

    • Hepatitis A
    • Hepatitis B
    • Japanese encephalitis – completion of an additional education module is mandatory
    • Poliomyelitis
    • Typhoid
    • Zoster vaccine – Shingrix only not Zostavax.

    The NSW Pharmacist Vaccination Standards and NSW Pharmacist Vaccine Authority have been amended to reflect this.

    Additional information regarding the NSW pharmacist vaccination program is available here.

  • Discontinued: Moderna Original COVID-19 vaccine

    Share Discontinued: Moderna Original COVID-19 vaccine on Facebook Share Discontinued: Moderna Original COVID-19 vaccine on Twitter Share Discontinued: Moderna Original COVID-19 vaccine on Linkedin Email Discontinued: Moderna Original COVID-19 vaccine link

    All sites will have their allocation for Moderna ancestral (red cap) set to zero in COVID-19 Vaccine Administrative System (CVAS) from Saturday 22 October 2022. Sites were able to place their last order for Moderna ancestral by midnight Friday 21 October 2022.

  • Caution: COVID-19 vaccine dosing & administration errors

    Share Caution: COVID-19 vaccine dosing & administration errors on Facebook Share Caution: COVID-19 vaccine dosing & administration errors on Twitter Share Caution: COVID-19 vaccine dosing & administration errors on Linkedin Email Caution: COVID-19 vaccine dosing & administration errors link

    Immunisation providers are advised to exercise caution especially when administering Moderna vaccines to avoid potential dosing errors and incorrect vaccine selection. Several vaccine administration errors (VAEs) have been reported since the roll-out of the Moderna Bivalent 18 years+ (Blue/Green) vaccine.

    The correct dosage of Moderna Bivalent 18 years + vaccine is 0.50mL (rather than 0.25mL). The vaccine comes in 2.5mL vials, with 5 doses contained within each vial. Providers are strongly advised to use the COVID vaccine comparison poster to check dose and brand suitability.



  • Update to AIR vaccination provider form

    Share Update to AIR vaccination provider form on Facebook Share Update to AIR vaccination provider form on Twitter Share Update to AIR vaccination provider form on Linkedin Email Update to AIR vaccination provider form link

    Two new provider types, Residential Care Facilities (RCFs) and Authorised Nurses Immunisers (ANIs) have been added to the Australian Immunisation Register (AIR) and can apply for an AIR Provider Number. This AIR update provides information and advice on possible scenarios.

    The advice is that a nurse in general practice is not required to get an AIR provider number and therefore an ABN is not needed.

    If someone is working as a contractor and needs an ABN they can apply directly to the ABR and there is no fee to get an ABN.

    Q In what settings should an ANI apply for an AIR provider number?

    A In NSW a Registered Nurse/Midwife who holds the relevant qualifications for administering immunisations independently, has an ABN and who:

    • plans on administering vaccines independently, or
    • administers vaccines at a location that does not already have or is unable to register for an AIR provider number





  • Amended Authority for Nurse/Midwife Immunisers and learning resource

    Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Facebook Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Twitter Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Linkedin Email Amended Authority for Nurse/Midwife Immunisers and learning resource link

    The Authority for Nurse/Midwife Immunisers has been amended to include the following additional vaccines:

    • Japanese encephalitis vaccines – mandatory training required
    • Typhoid vaccines
    • Herpes Zoster – Shingrix only. Does not include Zostavax

    The Authority is available from: https://www.health.nsw.gov.au/immunisation/Documents/authority-for-RNs-and-midwives.pdf

    In order to administer the Japanese encephalitis vaccines Authorised Nurse/Midwife Immunisers must have completed Japanese encephalitis: A resource for registered nurses and midwives

  • Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed

    Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Facebook Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Twitter Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Linkedin Email Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed link

    Researchers at the National Centre for Immunisation Research and Surveillance (NCIRS) are conducting a study investigating the current utilisation of vaccine safety surveillance systems by immunisation providers across Australia. To help inform this study, you are invited to participate in a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice.

    The findings from this study will help improve vaccine safety surveillance systems in Australia, ensuring they are fit-for-purpose for the needs of you and your patients in the future.

    Click here to register your interest

    Participants will be given a voucher for their time and interviews can be scheduled at a time that suits you to ensure there is no impact on your ability to see patients. Interviews will take place throughout October and November.

    For further information or if you have any questions about the study, please email NCIRS Senior Program Officer, Nicola Carter at Nicola.Carter@health.nsw.gov.au

    Expressions of interest close 30 October 2022.

  • Flu reimbursement - vendor invite not received??

    Share Flu reimbursement - vendor invite not received?? on Facebook Share Flu reimbursement - vendor invite not received?? on Twitter Share Flu reimbursement - vendor invite not received?? on Linkedin Email Flu reimbursement - vendor invite not received?? link

    If your practice has not received the vendor email invite to obtain your reimbursement for private flu vaccines. Please email kwisemantel@thephn.com.au with your details and best email address and I can action it with the Ministry of Health.

  • ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022)

    Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Facebook Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Twitter Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Linkedin Email ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) link

    The Australian Technical Advisory Group on Immunisation (ATAGI) has developed guidelines to provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. The guidelines are available on the Department of Health and Aged Care website.

    The latest version (7 September 2022) includes updated advice on incorrect storage and handling and consolidated advice on unapproved age group.

Page last updated: 06 Dec 2024, 12:35 PM